JPWO2021132577A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021132577A5
JPWO2021132577A5 JP2021567681A JP2021567681A JPWO2021132577A5 JP WO2021132577 A5 JPWO2021132577 A5 JP WO2021132577A5 JP 2021567681 A JP2021567681 A JP 2021567681A JP 2021567681 A JP2021567681 A JP 2021567681A JP WO2021132577 A5 JPWO2021132577 A5 JP WO2021132577A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021567681A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021132577A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/048775 external-priority patent/WO2021132577A1/ja
Publication of JPWO2021132577A1 publication Critical patent/JPWO2021132577A1/ja
Publication of JPWO2021132577A5 publication Critical patent/JPWO2021132577A5/ja
Withdrawn legal-status Critical Current

Links

JP2021567681A 2019-12-27 2020-12-25 Withdrawn JPWO2021132577A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019238920 2019-12-27
PCT/JP2020/048775 WO2021132577A1 (ja) 2019-12-27 2020-12-25 アシルスルファミド化合物及びその医薬用途

Publications (2)

Publication Number Publication Date
JPWO2021132577A1 JPWO2021132577A1 (https=) 2021-07-01
JPWO2021132577A5 true JPWO2021132577A5 (https=) 2024-01-09

Family

ID=76575358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021567681A Withdrawn JPWO2021132577A1 (https=) 2019-12-27 2020-12-25

Country Status (5)

Country Link
US (1) US20230399319A1 (https=)
EP (1) EP4082614A4 (https=)
JP (1) JPWO2021132577A1 (https=)
CN (1) CN114829345A (https=)
WO (1) WO2021132577A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322520A (en) * 2023-02-24 2025-10-01 Japan Tobacco Inc Modified pyrazolopyrimidine compounds and their medical use
JP7729000B2 (ja) * 2023-02-24 2025-08-25 日本たばこ産業株式会社 6-アルコキシピラゾロピリミジン化合物及びその医薬用途
AU2024229817A1 (en) * 2023-02-28 2025-08-14 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Chemical coupling linker and use thereof
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039099A1 (en) * 1998-12-24 2000-07-06 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
EP1357908A4 (en) * 2001-01-30 2009-07-15 Merck & Co Inc "ACYLSULFAMIDES FOR THE TREATMENT OF FATIBILITY, DIABETES AND LIPID DISORDERS"
US7144911B2 (en) * 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
PH12012500542A1 (en) * 2010-09-24 2012-11-12 Astellas Pharma Inc Substituted amide compound
AU2012351748B2 (en) * 2011-12-12 2016-04-14 Dr. Reddy's Laboratories Ltd. Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors
WO2013088315A1 (en) * 2011-12-15 2013-06-20 Pfizer Limited Sulfonamide derivatives
US20150291514A1 (en) * 2012-01-04 2015-10-15 Pfizer Limted N-Aminosulfonyl Benzamides
US10071957B2 (en) * 2012-07-06 2018-09-11 Genentech, Inc. N-substituted benzamides and methods of use thereof
JP2016506921A (ja) * 2013-01-30 2016-03-07 バイエル ファーマ アクチエンゲゼルシャフト アミノ置換イソチアゾール
KR102291444B1 (ko) * 2013-05-29 2021-08-18 브리스톨-마이어스 스큅 컴퍼니 디히드로피리디논 mgat2 억제제
CR20160296A (es) * 2013-11-27 2016-09-20 Genentech Inc Benzamidas sustituidas y métodos para usarlas
TWI735416B (zh) * 2014-10-06 2021-08-11 美商維泰克斯製藥公司 囊腫纖維化症跨膜傳導調節蛋白之調節劑
US10899732B2 (en) * 2015-11-25 2021-01-26 Genentech, Inc. Substituted benzamides useful as sodium channel blockers
CN109071454B (zh) * 2016-02-16 2023-02-17 昆士兰大学 磺酰脲和相关化合物及其用途
WO2019034693A1 (en) * 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
MX2020001776A (es) * 2017-08-15 2020-03-24 Inflazome Ltd Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3.
EP3759077A1 (en) * 2018-03-02 2021-01-06 Inflazome Limited Novel compounds

Similar Documents

Publication Publication Date Title
JP2022028828A5 (https=)
JP2022025124A5 (https=)
JP2021185136A5 (https=)
JP2021169491A5 (https=)
JP2022068302A5 (https=)
JP2021028398A5 (https=)
JP2023116721A5 (https=)
JP2021038271A5 (https=)
JP2024023385A5 (https=)
JP2023022224A5 (https=)
JP2020042034A5 (https=)
JP2020127428A5 (https=)
JP2022523200A5 (https=)
JP2024016014A5 (https=)
JP2021518389A5 (https=)
JP2023100643A5 (https=)
JP2022060295A5 (https=)
JP2025506484A5 (https=)
JP2022537813A5 (https=)
JP2020171301A5 (https=)
JP2020120660A5 (https=)
JP2021524864A5 (https=)
JP2022022379A5 (https=)
JP2023085551A5 (https=)
JP2024534771A5 (https=)